FBXO31 Activators encompass a variety of chemical compounds that indirectly promote the activity of FBXO31, a protein that plays a pivotal role in the ubiquitin-proteasome system, responsible for protein degradation and turnover. Forskolin and Rolipram both act to increase intracellular cAMP levels, with Forskolin directly stimulating adenylyl cyclase and Rolipram inhibiting phosphodiesterase-4, thereby preventing cAMP breakdown. The resulting elevation in cAMP levels enhances the ubiquitin-proteasome pathway, where FBXO31 functions to label proteins for degradation. Similarly, MG132's function as a proteasome inhibitor paradoxically results in an increase in proteasome pathway activity upon removal, which can upregulate FBXO31 activity. Biocytin, by promoting protein biotinylation, and Lithium Chloride, through the inhibition of GSK-3, both contribute to enhancing the SCF complex and ubiquitination processes that are central to FBXO31's action.
On the epigenetic front, Trichostatin A (TSA) and Sodium Butyrate act as histone deacetylase inhibitors, potentially increasing the expression of proteins that become substrates for FBXO31, thereby increasing the demand for its ubiquitination activity. Beta-Lapachone's effect on cellular redox states through the upregulation of NAD(P)H quinone oxidoreductase activity, as well asPDTC's role as an NF-κB inhibitor, can also modulate the abundance of FBXO31's substrates. Additional indirect activators include Resveratrol, which activates SIRT1 leading to the deacetylation of proteins, thus potentially enhancing the substrates available for FBXO31-mediated ubiquitination. Zinc Pyrithione affects metalloproteinase activity, which may impact the turnover of extracellular matrix components and consequently alter intracellular signaling pathways that dictate the need for FBXO31's role in protein turnover. Lastly, Curcumin, known for its NF-κB inhibitory effects, may also influence the expression of proteins within the ubiquitin-proteasome system, thereby promoting the functional activity of FBXO31. Collectively, these compounds, through their diverse biochemical actions, facilitate the enhancement of FBXO31's role in the regulated degradation of proteins, critical for maintaining cellular homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase leading to an increase in cAMP levels. Elevated cAMP enhances the ubiquitin-proteasome pathway, which FBXO31 is a part of by marking proteins for degradation. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits phosphodiesterase-4, preventing cAMP breakdown, thus indirectly enhancing FBXO31 activity by promoting the proteasomal degradation pathway. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits GSK-3, which may lead to enhanced activity of the SCF complex, and thus potentiate FBXO31's role in ubiquitin-ligase mediated degradation. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate, another histone deacetylase inhibitor, may similarly increase the expression of substrates for FBXO31-mediated ubiquitination. | ||||||
β-Lapachone | 4707-32-8 | sc-200875 sc-200875A | 5 mg 25 mg | $112.00 $459.00 | 8 | |
Beta-Lapachone increases NAD(P)H quinone oxidoreductase activity, which can indirectly enhance FBXO31 by modulating cellular redox states that affect ubiquitination processes. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates SIRT1, which can deacetylate substrates and may enhance the ubiquitination process where FBXO31 is involved. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin inhibits NF-κB signaling, which can lead to the alteration of protein expression profiles and enhance the ubiquitin-proteasome system involving FBXO31. | ||||||